Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
0.5622
-0.0539 (-8.75%)
At close: Oct 21, 2026, 4:00 PM EDT
0.5900
+0.0278 (4.94%)
After-hours: Oct 21, 2026, 6:20 PM EDT
Actuate Therapeutics Market Cap
Actuate Therapeutics has a market cap or net worth of $13.5 million as of October 21, 2026. It is the 39,092nd most valuable company in the world and the 5,380th biggest in the United States. Its market cap has decreased by 92.02% in one year.
Market Cap
13.50M
Enterprise Value
9.07M
1-Year Change
-92.02%
Global Rank
Country Rank
#5,380 United States
Category
ChartMarket Cap Chart
Since the IPO on August 13, 2024, Actuate Therapeutics's market cap has decreased from $152.13M to $13.50M, a decrease of -91.13%. That is a compound annual growth rate of -66.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 13.50M | -90.51% |
| Dec 31, 2025 | 142.25M | -8.50% |
| Dec 31, 2024 | 155.47M | 2.20% |
| Aug 13, 2024 | 152.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioCardia | 15.84M |
| NewcelX | 15.77M |
| TScan Therapeutics | 15.55M |
| Kiora Pharmaceuticals | 14.95M |
| Dyadic International | 14.67M |
| Allarity Therapeutics | 14.26M |
| Tvardi Therapeutics | 13.87M |
| Pasithea Therapeutics | 13.70M |